We reiterate our HOLD on Lotus Bakeries but increase our target price from €9,999 to €12,000 on the back of a significant volume growth beat in 1H24, while our WACC is lowered modestly to reflect lower 10-year yields in the United States. We continue to view Lotus Bakeries as a unique growth story in the FMCG segment, with more than a decade of self-funded organic growth ahead. However, we believe that the valuation of the company already reflects these growth prospects, with our model forecasti...
ING Benelux Conference London: Aalberts, Arcadis, Azelis, Barco, Basic-Fit, Brunel International, DEME Group, Euronext, Fagron, Heijmans, Kinepolis, Lotus Bakeries, Melexis, Ontex, Randstad, Recticel, SBM Offshore, TKH Group, Van Lanschot Kempen Other company stories - OCI: Divestment of Methanol to Methanex for US$2.05bn, Staffing: US August temp volumes marginally better trend; NFP jobs miss
We updated our model after Lotus Bakeries reported 1H24 sales of €599.3m, up 19.6% y/y, mainly driven by robust and broad-based volume growth of more than 16% across the three strategic pillars. In addition, there was a 3% y/y price effect, combined with FX impact. We saw a) continued momentum and outstanding volume growth in Lotus Biscoff; b) Lotus Natural Foods also continues to outperform the market with double digit growth; and c) Lotus Local Heroes delivered mid-single digit growth above hi...
B&S: Preview - chasing growth, battling cost inflation. CTP: 1H24 results call highlights. D'Ieteren: Belron US peer Boyd reports slightly better 2Q24 but outlook still weak. Fastned: Preview 1H24. Lotus Bakeries: Strong volume growth beat. Xior Student Housing: 1H24 results call highlights. Coverage change
The Stoxx 600 gained just 1.1% in July after shedding 1.3% in June, driven by the SMI (+2.5%) and the Footsie 100 (+2.7%). With business sentiment indicators continuing to weaken, defensive stocks outperformed cyclicals in July, and many healthcare stocks were among the best performers of the Stoxx 600. Long-term interest rates have fallen sharply (probably too much), but this has not benefited tech and luxury goods stocks, penalised by their disappointing results publications. - ...
Le Stoxx 600 ne progresse que de 1,1% en juillet après sa baisse de 1,3% en juin, tiré par le SMI (+2,5%) et le Footsie 100 (+2,7%). Avec la poursuite du fléchissement des indicateurs de climat des affaires, les défensives ont surperformé les cycliques en juillet, et de nombreuses valeurs Santé sont présentes parmi les meilleures performances du Stoxx 600. Les taux d’intérêt longs ont nettement reflué (sans doute trop) sans que cela profite aux valeurs de la Tech ou du Luxe qui ont s...
>At group level, solid Q2 2024 results: EBITDA growth of 10% - Due predominantly to Argentina and China, ABI’s volumes decreased by 0.8% in Q2 2024, which was in line with our estimate. EBITDA growth was 10.2% in Q2 2024, ahead of forecasts. The organic EBITDA growth of 7.8% in H1 2024 implies growth at the high end of the 4-8% guidance range for full year 2024. Underlying net profit beat our expectation by some 9% in the quarter. ABI’s net debt and financial leverage...
ABN Amro: CEO leaving in 1H 25, another management change AB InBev: Does what it says on the can AMG: Solid 2Q24 beat and guidance raise, Brazil on track for full capacity by 4Q24 Aperam: Good quarter on EBITDA and FCF, 3Q24 guide in-line Ayvens: Mixed bag Azelis: In-line 2Q24, cautious return to organic growth in Americas yet outlook remains fragile Fagron: Nice 2Q24 beat and guidance raise, higher capex to support growth Fugro: 15% beat but missing balance in its results GBL: Lackluster NAV pe...
>EBITDA and organic EBITDA growth slightly ahead of expectations in Q2 2024 - ABI reported an organic volume decline of 0.8% to 146.3m hl (ABNe: -0.9% and 146.2m hl, consensus: -0.6% and 146.7m hl). Organic revenue growth was 2.7% to $ 15,333m (ABNe: $15,600m and 4.0%, consensus: $ 15,483m and 3.5%). EBITDA came in at $ 5,302m with organic growth of 10.2% (ABNe: $ 5,234m and 8.2%, consensus: $ 5,280m and 8.3%). Underlying net profit and EPS were $ 1,811m and $ 0.90, ...
2Q organic EBITDA growth was slightly higher than expected at +10.2%. ABI maintained FY 24 guidance of 4-8% EBITDA growth which seems conservative at the lower end of the range given the 1H growth of 7.8% whilst the US Bud Light saga is now fully cycled (since 2Q). We still appreciate ABI for its leadership positions in the global beer market, high intrinsic profitability and LT growth prospects in its emerging markets businesses. Deleveraging is on track and with valuation multiples attractive,...
BRUSSELS--(BUSINESS WIRE)-- Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: AB InBev Strategic Priorities (Graphic: Business Wire) Regulated information1 “Our global momentum continued this quarter. The strength of our diversified footprint and consumer demand for our megabrands delivered another quarter of broad-based top- and bottom-line growth. EBITDA grew by double-digits and the continued optimization of our business drove a 25% increase in Underlying EPS. We are encouraged with our performance in th...
BRUXELLES--(BUSINESS WIRE)-- Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): Ce communiqué de presse contient des éléments multimédias. Voir le communiqué complet ici : AB InBev Strategic Priorities (Graphic: Business Wire) Information réglementée1 « Notre dynamique mondiale s’est poursuivie ce trimestre. La force de notre empreinte diversifiée et la demande des consommateurs pour nos méga-marques nous ont permis de réaliser à nouveau une croissance généralisée des produits et des bénéfices au cours de ce trimestre. L’EBITDA a enregistré une croissance à deux chiffres et ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.